Skip to contentL
LifeMD, Inc.
L
LFMDLifeMD, Inc. Q3 2024 · 10-Q
Revenue$53.27M$53.27M+38.0% vs Q3 2023 Net Income-$4.66M-$4.66MN/M vs Q3 2023 EPS Diluted-$0.13-$0.13N/M vs Q3 2023 Gross Profit$48,258,753+42.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
LifeMD, Inc. · CIK 948320 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,697,967+522.4% Free Cash Flowderived$6,250,165+497.6% Margins · derivedGross margin90.6%+3.0 pt vs Q3 2023
Operating margin-7.5%+4.3 pt vs Q3 2023
Net margin-8.7%+7.1 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end